31st Annual Meeting of the ANPA
Wednesday, March 17, 2021: 9:00 AM – 4:30 PM EST – Pre-Meeting Symposia
Thursday, March 18, 2021: 8:45 AM – 8:15 PM EST – Main Conference
Friday, March 19, 2021: 8:45 AM – 7:00 PM EST – Main Conference
Saturday, March 20, 2021: 8:45 AM – 4:30 PM EST – Main Conference
Please review the important information in this email to help you prepare for this week’s 31st Annual Meeting of the ANPA.
The virtual platform opens daily, 60 minutes prior to the start of the session times noted above. We suggest logging in early to familiarize yourself with the virtual platform. To access the lobby, you must be registered. Please Click here to log in with your email. We recommend using Chrome as your dedicated web browser.
The on demand sessions will be posted the following day and will remain available until April 30, 2021.
Please review the final agenda on the ANPA website. This will also be available for download within the virtual platform.
If you experience any technical difficulties or questions, please contact email@example.com. If you are in the virtual platform, you can also visit the Help Desk to connect with our staff.
We look forward to “seeing” you!
The ANPA meeting will be virtual but you DO NOT need to attend each day to receive CME and MOC credits! The videos will be available through April 30, 2021 for meeting registrants. Therefore, if you can attend only Thursday and Saturday, you can get credit for the symposiums for Wednesday and Friday at your convenience through April 30th!
31st ANPA ANNUAL MEETING AGENDA
March 17 – 21, 2021
(Times shown are Eastern Standard Time)
Wednesday, March 17, 2021 - Pre-Meeting Symposia 1 - Neuropsychiatry of Chronic Pain - 8:45a EST
9:00 am - Balanced Approach to Treating Chronic Pain - Kurt Kroenke, MD
9:45 am Neuroimaging Based Biomarkers for Pain - Tor Wager, Ph.D.
10:30am Mechanisms and Management of Chronic Pain - Michael Rowbotham, MD
11:15 am – Live Q&A Session
Wednesday, March 17, 2021 - Pre-Meeting Symposia 2- Daniel Kaufer Behavioral Neurology and Neuropsychiatry Workshop 1:00 pm EST
1:00 pm Introduction & Case Presentation - White Matter - Chris Filley, MD and Jeremy Schmahmann, MD
2:00 pm White Matter Behavior-Relationships - Jeremy Schmahmann, MD
3:15 pm White Matter Restoration & Plasticity - Chris Filley, MD
4:15 pm - Live Q&A Session
4:45 pm – Advisory Committee (Invitation Only)
Thursday, March 18, 2021
8:45 - Welcome & Opening - Omar Ghaffar, MD and Robin Hurley, MD
Neuropsychiatry of the Catatonic Syndrome
9:00 am - Clinical Assessment of Catatonia - Andrew Francis, MD
9:45 am - Treatment of Catatonia - Scott Beach, MD
10:30 am - Pathophysiology of the Catatonic Syndrome - Gregory Fricchione, MD
11:15 am – Live Q&A
12:30 pm – PRACTICE WORKSHOPS – Introduction by David Arciniegas, MD
12:30 pm – Practice Workshop 1 – Clinical Presentation of Catatonia
Andrew Francis, MD
1:15 pm – Practice Workshop 2 – Clinical Assessment of Disorders of Consciousness
John Whyte, MD
2:00 pm – Live Q&A
The Salience Network
3:00 pm - Common Impairments in Cognitive & Emotional Processing in Mental Illness: The Salience Network and Beyond – Lisa McTeague, Ph.D.
3:45 pm - Brain aging and the salience network: Implications for cognitive control and TMS response in MDD – Katherine Dunlop, Ph.D.
4:30 pm - Surprising Interactions between Central Executive and Saliency Network Nodes during Novelty Seeking – Vincent Costa, Ph.D.
5:15 pm – Live Q&A
6:15 pm Committee on Research – Introduction by Simone Ducharme, MD
6:15 pm - Functional Cognitive Disorders - Systematic Review & Best Practice Approach - Mandana Modirrousta, MD and Selma Aybeck, MD
7:15 pm – Unmet Needs in Neuropsychiatric Research – Ottavio Vitolo, MD
8:00 pm – Live Q&A
Friday, March 19, 2021
8:45 – Welcome and Opening – Robin Hurley, MD
Presidents Symposium - Perspectives on the Tinnitus Brain
9:00 am – Hearing and Mental Health Considerations in the Tinnitus Clinic–
Marc Fagelson, Au.D.
9:45 am – Invasive and non-invasive investigations of human tinnitus perception –
Phillip Gander, Ph.D.
10:30 am – Tinnitus and Diminished Sound Level Tolerance as a Window on the Brain
Will Sedley, Ph.D.
11:15 am – Live Q&A
12 Noon – Research & Clinical Platform Presentations – Moderators Michael Schrift, MD
And David Perez, MD
12:15 pm – Clinical Platform Presentations
Early Onset Dementia with Early and Prominent Behavioral Features due to Prion Disease Associated with Nine Octapeptide Repeat Insertion in the PRNP Gene
Author(s): Aaron Ritter, Maileen UlepReed, Trevor Campbell, Paul Gentle, and Dylan Wint
A Brain Obsessed: A Case of Severe OCD as the Presenting Symptom of Epilepsy
Author: Tamar C. Katz, MD PhD
The Covid-19 “Long-Hauler” Represented as a Case of Functional Neurological Disorder
Authors: Geoffrey Raynor, Ginger Polich, Gaston Baslet
Clinical and Radiologic Features of the Globular Glial Tauopathy Subtype of Frontotemporal Lobar Degeneration in a Case of bvFTD with Geschwind Syndrome
Authors: Sylvia Josephy-Hernandez, David DongkyungKim, Megan Quimby, Michael Brickhouse, Alexandra Touroutoglou, Samantha Champion, Matthew Frosch, Bradford C. Dickerson
Help, My Family Thinks It Is all in my Head! A Case of NeurosarcoidosisInduced Neurobehavioral Disturbances
Authors: Alvaro J. La Rosa, Jennifer M. Erickson, Brenna B. Stanczyk, Zoe E. Renner, Amelia N. Dubovsky
A Case of MAPT Mutation Frontotemporal Dementia Presenting as Cerebellar Ataxia
Authors: Jake P. Levy, Simon Ducharme
1:15 pm – Research Platform Presentations
A Very Brief Dementia Questionnaire Correlates with Well-Established Measures of Disease Severity
Author(s):Francesca R. Dino, James R. Bateman, Daniel D. Matlock, Daniel I. Kaufer, Peter S. Pressman
Impact of Body Composition on NIH Toolbox Cognition Battery Scores among Community Dwelling, Older Adults with Obesity
Authors: Henry D. Heisey, Mark E. Kunik, Arjun Paudyal, Dennis T. Villareal
Sustained Improvement after Completion of Mindfulness-Based Psychotherapy for Psychogenic Nonepileptic Seizures
Authors: Gaston Baslet, Barbara A. Dworetzky, Laura Morrissey, Robert Ridlon, Margaret Latawiec.
Network Localization of Spontaneous Confabulation
Authors: James R. Bateman, Michael A. Ferguson, C. Alan Anderson, David B. Arciniegas, Asaf Gilboa, Brian D. Berman, and Michael D. Fox.
Large Scale Lesion Symptom Mapping of Depression Identifies Distinct Brain Regions for Risk and Resilience
Authors:Nicholas T. Trapp, Joel Bruss, Shuwen Li, Fatimah Albazron, Kenneth Manzel, Jordan Grafman, Daniel Tranel, Aaron D. Boes
Interactions between Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline: The Mayo Clinic Study of Aging
Authors: Janina Krell-Roesch, Jeremy A. Syrjanen, Luke R. Christenson, Ronald C. Petersen, Maria Vassilaki, Yonas E. Geda
2:15 pm – Live Q&A
3:30 pm – Poster Presentations
Poster Presentations will feature all accepted abstracts/posters in a virtual room
5:30 pm – Neuropsychiatry Bazaar and Special Interest Group Meeting
Saturday, March 20, 2021
8:45 am – Introduction
9:00 am – ** Bassoe Lecture by Edward Boyden, Ph.D. **
Technologies for Analyzing and Controlling Brain Circuits
9:45 am – Live Q&A
10:00 am – The Experience of Living with a Biomarker Based Diagnosis of Alzheimers
Disease – Jason Karlawish, MD
10:45 am – Live Q&A
11:00 am – Cognitively Impaired Physicians: Institutional Challenges and Personal Choices
Kirk Daffner, MD
11:45 am – Live Q&A
12:15 pm – Special Interest Group Symposia
12:15 pm – SIG 1: Neuropsychiatry of Magic – Barbara Schildkrout, MD, Kathy Niu, MD and
Magician Daniel Roy
1:00 pm – Live Q&A
1:15 pm - SIG 2: Management of Agitation & Aggression in Dementia
Trey Bateman, MD – Old Standbys and New Tricks
Laura Flashman, Ph.D. – Behavioral Approaches to Minimizing Agitation &
Aggression in Dementia
Elaine Peskind, MD – Title to be determined
2:00 pm – Live Q&A
2:15 pm – Awards – Robin Hurley, MD
This session will include recognizing 2020 and 2021 new ANPA Fellows, Career Development Award winners, Young Investigator award winners and Clinical Neuroscience Trainee award winners. The session will also include the introduction of newly elected Council Members.
3:15 pm – Presidential Address – Kaloyan Tanev, MD
Case of Occipito-Temporal Stroke. History Art and Science of Neuropsychiatric Practice
4:00 pm – Live Q&A
4:30 pm - Special Event for Early Career Participants!
Sunday, March 21, 2021
11:00 am - Business Meeting (Zoom) Invitation will be sent to meeting registrants
THE ANPA LOOKS FORWARD TO SEEING YOU
NOTE: Can’t attend a particular session? Paid registrants will be able to access lectures “on demand”
until April 30, 2021 for CME and CE credit
The Medical University of South Carolina Office of Continuing Medical Education has reviewed and approved your application for a maximum of 23.50 AMA PRA Category 1 CreditsTM.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical University of South Carolina and the American Neuropsychiatric Association. The Medical University of South Carolina is accredited by the ACCME to provide continuing medical education for physicians.
Dr. Peter Bassoe (1874-1945) was a Chicago-based neurologist-neuropsychiatrist as well as the founder and inaugural President of the Central Neuropsychiatric Association (CNPA, est. 1922). Dr. Bassoe founded the CNPA “to foster the advancement of neurologic, neurosurgical, and psychiatric sciences in the mid-continental United States.” Guided by his vision, this organization flourished during the decades of the mid-twentieth century. The Peter Bassoe Fund was established within the CNPA in 1982 for the purpose of providing funds for continuing education activities, scholarships, awards for essays submitted by residents, and other expenses of the scientific portion of the meeting.
In 2001, following several decades of changes to the organizational and political landscape in the clinical neurosciences, CNPA merged with ANPA. As a component of the merger agreement between our associations, CNPA directed ANPA to use the Bassoe Fund to support a Keynote Address at the ANPA annual meeting and to identify it as the Peter Bassoe Lecture.
In tribute to Dr. Bassoe and CNPA, the Peter Bassoe Lecture is given by a world-class clinical neuroscientist at the ANPA Annual Meeting. The lecture provides a forum for a high-level review in the area of neuroscience to which the Peter Bassoe Lecturer has contributed. Additionally, it provides an opportunity for the lecturer to discuss the implications of his or her work on the education and training of clinician-neuroscientists, including subspecialists in behavioral neurology & neuropsychiatry.
2021 American Neuropsychiatric Association Virtual Annual Meeting
March 17 – 20, 2021
According to the ACCME Standards of Commercial Support, a conflict of interest is present when individuals in a position to control the content of CME have a relevant personal financial relationship (i.e. speaker honoraria, consultant fees, contracted research, stock/shareholder, etc.) with an ineligible company* that benefits the individual and may ultimately bias the content of CME activities to learners. A potential conflict of interest may exist if there is (1) a relevant financial relationship (in any amount) with an ineligible company occurring within the past 12 months, and (2) the opportunity to influence the content of CME concerning the products or services of that ineligible company.
*Per the ACCME, an ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
The Medical University of South Carolina, as an ACCME provider, requires that all presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The Medical University of South Carolina recommends that each physician fully review all the available data on new products or procedures prior to instituting them with patients.
Planners/Directors/Presenters/Moderators with Relevant Financial Relationships
Kevin J. Black, MD– Consultant – Cenobamate; Research Grant – Emalex Biosciences
Simon Ducharme– Research Grants – Biogen and Ionis Pharmaceuticals; Advisory
Committee/Board – Eisai; Speakers Bureau – Sunovion Pharmaceuticals
Jason Karlawish– Research Grants – Eli Lilly
Lisa M. McTeague, PhD – Consultant – AbleTo.com and Joyable.com
Jeremy D. Schmahmann– Consultant – Bayer, Biogen, Cadent; Research Grants – Biohaven
Ottavio V. Vitolo– Stock – Relmada Therapeutics, Inc.; Consultant – Alcyone Therapeutics, Inc.
Planners/Directors/Presenters/Moderators with NO Relevant Financial Relationships
James R. Bateman, III, MD, MPH
C. Edward Coffey, MD
Kirk R. Daffner, MD
Marc Fagelson, PhD
Christopher M. Filley
Laura A. Flashman
Manish A. Fozdar, MD
Gregory L. Fricchione, MD
Robin A. Hurley, MD, FANPA
David L. Perez, MD, MMSc
Michael C. Rowbotham
Jeremiah Scharf, MD, PhD
Katherine H. Taber
Tor Wagner, PhD
John Whyte, MD, PhD